In 1992, Congress created what’s commonly known as the 340B program in order to help safety-net hospitals and clinics stretch limited resources to serve low-income and uninsured patients. 

By requiring pharmaceutical manufacturers to sell prescription drugs at steep discounts to qualifying hospitals and clinics, the logic went, the 340B program aimed to keep medications accessible and affordable in underserved communities.